---
title: "AstraZeneca (AZN) Receives a Buy from Berenberg Bank"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301123336.md"
description: "Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca today and set a price target of £150.00. Hector covers the Healthcare sector, focusing on stocks such as AstraZeneca, Sanofi, and Roche Holding AG. According to TipRanks, Hector has an average return of 4.6% and a 56.12% success rate on recommended stocks. In addition to Berenberg Bank, AstraZeneca also received a Buy from Bernstein’s Justin Smith in a report issued today. However, on September 29, Deutsche Bank maintained a Hold rating on AstraZeneca (LSE: AZN)."
datetime: "2026-10-07T08:07:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301123336.md)
  - [en](https://longbridge.com/en/news/301123336.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301123336.md)
generator: "portal-rs"
---

# AstraZeneca (AZN) Receives a Buy from Berenberg Bank

Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca today and set a price target of £150.00.

Hector covers the Healthcare sector, focusing on stocks such as AstraZeneca, Sanofi, and Roche Holding AG. According to TipRanks, Hector has an average return of 4.6% and a 56.12% success rate on recommended stocks. 

In addition to Berenberg Bank, AstraZeneca also received a Buy from Bernstein’s Justin Smith in a report issued today. However, on September 29, Deutsche Bank maintained a Hold rating on AstraZeneca (LSE: AZN).

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [SNY.US](https://longbridge.com/en/quote/SNY.US.md)

## Related News & Research

- [FACTBOX-Global healthcare companies invest billions to boost US presence](https://longbridge.com/en/news/301028209.md)
- [AstraZeneca: SERENA-4 Trial Of Etcamah Palbociclib Combination Fails To Meet Primary Objective](https://longbridge.com/en/news/298875452.md)
- [Key facts: AstraZeneca (AZN) NICE OK Enhertu; FDA review; China plan](https://longbridge.com/en/news/299411391.md)
- [Summit Stock Jumps 17% on $2 Billion AstraZeneca Investment](https://longbridge.com/en/news/300462366.md)
- [REG - AstraZeneca PLC - Trixeo approved in EU for asthma](https://longbridge.com/en/news/299849937.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**